• 제목/요약/키워드: tracheobronchitis

검색결과 21건 처리시간 0.029초

Aspergillus Tracheobronchitis in a Mild Immunocompromised Host

  • Cho, Byung Ha;Oh, Youngmin;Kang, Eun Seok;Hong, Yong Joo;Jeong, Hye Won;Lee, Ok-Jun;Chang, You-Jin;Choe, Kang Hyeon;Lee, Ki Man;An, Jin-Young
    • Tuberculosis and Respiratory Diseases
    • /
    • 제77권5호
    • /
    • pp.223-226
    • /
    • 2014
  • Aspergillus tracheobronchitis is a form of invasive pulmonary aspergillosis in which the Aspergillus infection is limited predominantly to the tracheobronchial tree. It occurs primarily in severely immunocompromised patients such as lung transplant recipients. Here, we report a case of Aspergillus tracheobronchitis in a 42-year-old man with diabetes mellitus, who presented with intractable cough, lack of expectoration of sputum, and chest discomfort. The patient did not respond to conventional treatment with antibiotics and antitussive agents, and he underwent bronchoscopy that showed multiple, discrete, gelatinous whitish plaques mainly involving the trachea and the left bronchus. On the basis of the bronchoscopic and microbiologic findings, we made the diagnosis of Aspergillus tracheobronchitis and initiated antifungal therapy. He showed gradual improvement in his symptoms and continued taking oral itraconazole for 6 months. Physicians should consider Aspergillus tracheobronchitis as a probable diagnosis in immunocompromised patients presenting with atypical respiratory symptoms and should try to establish a prompt diagnosis.

거짓막성 아스페르길루스 기관-기관지염: 기도침습성 아스페르길루스증의 희귀한 발현에 대한 증례 보고 (Pseudomembranous Aspergillus Tracheobronchitis: Case Report of a Rare Manifestation of Airway Invasive Aspergillosis)

  • 조재성;김정재;정선영;이연수;김미옥;박성준;고명주
    • 대한영상의학회지
    • /
    • 제83권3호
    • /
    • pp.737-743
    • /
    • 2022
  • 아스페르길루스 기관-기관지염은 침습성 폐 아스페르길루스의 매우 드문 형태 중 하나로 주로 기관-기관지에 국한되어 거짓막이나 궤양을 형성하거나 폐쇄를 유발하는 질환이다. 거짓막성 아스페르길루스 기관-기관지염은 아스페르길루스 기관-기관지염 중 가장 심한 형태로 대게는 면역저하자에서 발병하고 예후가 좋지 않다. 현재까지 이 질환에 대해 몇 개의 국내보고가 있으나 영상 소견에 대한 보고는 드물다. 이에 저자들은 기관지경 검사상 거짓막성 아스페르길루스 기관-기관지염으로 진단되고 적절한 항진균제 투여로 성공적으로 치료된 환자의 증례를 특징적인 영상 소견과 함께 보고하고자 한다.

아스페르길루스 기관기관지염에 의한 사망: 부검 1예 (Death due to Aspergillus Tracheobronchitis: An Autopsy Case)

  • 유택균;최병하;이봉우;최영식
    • The Korean Journal of Legal Medicine
    • /
    • 제42권4호
    • /
    • pp.164-167
    • /
    • 2018
  • Aspergillus infection is the most common cause of death due to fungi in immunocompromised hosts. Aspergillus tracheobronchitis is an uncommon but severe form of invasive pulmonary aspergillosis, which is limited entirely or mainly to the tracheobronchial tree and can often be life-threatening. We report a case of a 54-year-old man who died from Aspergillus tracheobronchitis without an underlying disease. Autopsy revealed an extensive yellowish plaque adhering to the trachea and bronchial wall. The microscopic examination of the trachea and bronchus revealed septate branching hyphae of Aspergillus.

A Case of Severe Pseudomembranous Tracheobronchitis Complicated by Co-infection of Influenza A (H1N1) and Staphylococcus aureus in an Immunocompetent Patient

  • Park, Sung Soo;Kim, Seung Hoon;Kim, Mihee;Kim, Jong Wook;Ko, Yoo Mi;Kim, Sung-Kyoung;Kim, So Hyang;Kim, Chi Hong
    • Tuberculosis and Respiratory Diseases
    • /
    • 제78권4호
    • /
    • pp.366-370
    • /
    • 2015
  • Although influenza A (H1N1) virus leads to self-limiting illness, co-infection with bacteria may result in cases of severe respiratory failure due to inflammation and necrosis of intra-airway, as pseudomembranous tracheobronchitis. Pseudomembranous tracheobronchitis is usually developed in immunocompromised patients, but it can also occur in immunocompetent patients on a very rare basis. We report a case of pseudomembranous tracheobronchitis complicated by co-infection of inflenaza A and Staphylococcus aureus, causing acute respiratory failure in immunocompetent patients.

Aspergillus 기관-기관지염 1예 (A Case of Aspergillus Tracheobronchitis in Non-Immunocompromised Patient)

  • 정효영;김휘종;김수희;이종덕;황영실
    • Tuberculosis and Respiratory Diseases
    • /
    • 제49권4호
    • /
    • pp.508-513
    • /
    • 2000
  • Aspergillus에 의한 기관-기관지염은 침습성 폐 국 균증의 한 분류로써 드문 질환이다. 저자들은 aspergillus에 의한 기관-기관지염증 aspergillus 기관-기관지염을 경험하고 성공적으로 치료하였기에 문헌고찰과 함께 보고하는 바이다.

  • PDF

면역적격환자에서 발생한 위막성 아스페르길루스 기관기관지염 1예 (Pseudomembranous Aspergillus Tracheobronchitis in an Immunocompetent Patient)

  • 차승익;신경민;유승수;정지윤;윤길숙;이신엽;김창호;박재용;정태훈
    • Tuberculosis and Respiratory Diseases
    • /
    • 제65권5호
    • /
    • pp.400-404
    • /
    • 2008
  • 아스페르길루스 기관기관지염은 침습적 폐 아스페르길루스증의 일종으로 심한 기관기관지염과 위막형성을 특징으로 한다. 이 질환은 일반적으로 면역억제 환자에서 발생하며 치명률이 높은 질환이다. 저자들은 비교적 건강하던 환자에서 발생하였고 항진균제에 잘 반응하였던 아스페르길루스 기관기관지염을 1예 경험하였기에 보고하는 바이다.

개 전염성 기관기관지염에 대한 modified live vaccine의 방어효과 (Effects of the modified live vaccines against Bordetella bronchiseptica and canine parainfluenza virus)

  • 박영일;노인순;한정희
    • 한국동물위생학회지
    • /
    • 제31권1호
    • /
    • pp.57-70
    • /
    • 2008
  • The purpose of this study was to investigate the protective effects of the modified live vaccines against canine Bordetella bronchiseptica (Bb) and canine parainfluenza virus (CPIV) in puppies by nasal administration. A total of 24 puppies were classified as 3 groups consisting of 8, and each one was divided into two subgroups; vaccinated (n=4) and unvaccinated (n=4). Group I, group II and group III were challenged with Bb, CPIV, and Bb+CPIV, respectively. In group I vaccinated puppies (n=4) were experimentally challenged with Bb 2 weeks after vaccination and unvaccinated puppies (n=4) were experimentally challenged with Bb alone. The same methods of the above were applied for group II and group III. We carried out several studies including serum tests, isolation, and histopathological examination. The vaccinated puppies showed higher antibody titers than unvaccinated puppies and the titer sustained during the experimental period. In the isolation test, recovery period was shorter in the vaccinated subgroup than in the other. In clinical signs, the unvaccinated puppies showed the typical signs of tracheobronchitis (coughing, nasal and occular discharge), but another subgroup showed delayed incidence and mild clinical signs. The typical gross lesions and histopathological findings were observed in the unvaccinated puppies. In immunohistochemical findings, the vaccinated puppies showed little intensive in reaction for CPIV antigen than the other. It could be concluded that intranasal vaccination of modified live Bb and CPIV vaccine to puppies is effective to prevent canine infectious tracheobronchitis.

기관 및 기관지 결핵 61예의 임상적 고찰 (A Clinical Study on 61 Cases of Tuberculous Tracheobronchitis)

  • 안철민;김형중;황의석;김성규;이원영;김상진
    • Tuberculosis and Respiratory Diseases
    • /
    • 제38권4호
    • /
    • pp.340-346
    • /
    • 1991
  • Tuberculous tracheobronchitis is defined as a specific inflammation of the trachea or major bronchi caused by the tubercle bacillus and recognized as one of the most common and serious complication of pulmonary tuberculosis. It had been a diagnostic challenge in prebronchoscopic era and since 1968, fiberoptic bronchoscopy has been accepted as a safe and valuable diagnostic procedure of tuberculous tracheobronchitis. Now, it remains a troublesome therapeutic problem due to its sequelae such as bronchostenosis, bronchiectasis and bronchial deformity. The authors analyzed the clinical features, radiological findings and bronchoscopic findings with pathologic and bacteriologic study on 61 cases of tuberculous tracheobronchitis and following results were obtained. 1) The peak incidence was in the fourth decade and male to female ratio was 1:3.4. 2) The most common symptom was cough (86.9%) and followed by sputum (49.2%), dyspnea (27.9%), fever (19.8%), weight loss (11.5%), hemoptysis (6.6%), hoarseness (6.6%) and chest discomfort (3.3%) and localized wheezing was heard in 18%. 3) In chest X-ray, consolidation with collapse was observed in 70.5%, and followed by consolidation only (18.0%), mediastinal node enlargement (8.2%), cavitary lesion (6.6%), suspicious hilar mass (3.3%) and miliary lesion (1.6%) and there was no abnormal findings in 4.9%. 4) Bronchoscopy showed hyperplastic lesion in 67.2%, mucosal lesion (18.0%), ulcerative lesion (9.8%) and stenotic lesion (4.9%). The most common site of bronchial lesion was right upper bronchus (36.1%) and followed by right main bronchus (34.4%), left main bronchus (29.5%), left upper bronchus (16.4%), right middle bronchus (8.2%), right lower bronchus (6.6%) and left lower bronchus (3.3%). 5) Chronic granulomatous inflammation with or without caseation necrosis on microscopic examination was confirmed in 69.7%, bronchial washing AFB stain was positive in 34.1%, prebronchoscopic sputum AFB stain was positive in 88.1% and postbronchoscopic sputum AFB stain was positive in 30.1%.

  • PDF